WO2001087172A9 - Multi-channel rf energy delivery with coagulum reduction - Google Patents
Multi-channel rf energy delivery with coagulum reductionInfo
- Publication number
- WO2001087172A9 WO2001087172A9 PCT/US2001/015346 US0115346W WO0187172A9 WO 2001087172 A9 WO2001087172 A9 WO 2001087172A9 US 0115346 W US0115346 W US 0115346W WO 0187172 A9 WO0187172 A9 WO 0187172A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ablation
- temperature
- power
- electrode
- energy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/0016—Energy applicators arranged in a two- or three dimensional array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00357—Endocardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
- A61B2018/00648—Sensing and controlling the application of energy with feedback, i.e. closed loop control using more than one sensed parameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
- A61B2018/00678—Sensing and controlling the application of energy using a threshold value upper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00797—Temperature measured by multiple temperature sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00827—Current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00892—Voltage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
Definitions
- Radio frequency energy may be used to treat certain cardiac abnormalities, such as fibrillation, by ablating caridiac tissue.
- Radio frequency energy is delivered by RF generators in two phases: (i) the "ramp up” phase in which a relatively high amount of power is delivered to the ablating electrode until a desired set temperature is sensed by the thermocouple or thermistor, and (ii) the "regulation” phase in which power is still being delivered but regulated at a lower level to maintain the desired set temperature.
- This target temperature is predetermined by the operator, and is generally 50° to 55° C for ablation of cardiac tissue.
- RF generators have software modules which run simultaneously on portable computers during RF energy delivery to log the ablation episode.
- the parameters logged are sensed impedance, power delivered, as well as tissue temperature sensed by either thermistors or thermocouples. Currently, this information is typically used for post-procedural review.
- RF ablation of cardiac tissue The challenge in RF ablation of cardiac tissue is to create deep lesions in the cardiac tissue while avoiding coagulum formation. It follows that RF energy must be delivered efficiently into the tissue, and not delivered and lost into the blood medium. Current methods and systems are not adequate to assure that RF energy is delivered efficiently to cardiac tissue during an ablation procedure.
- the methods and systems of the current invention provide efficient delivery of radio frequency (RF) energy to cardiac tissue with an ablation catheter, thereby yielding consistently effective RF ablation procedures and improved patient outcomes.
- RF radio frequency
- the methods and systems of the current invention deliver RF energy to cardiac tissue simultaneously through a series of channels in a manner that is designed to minimize the risk of an ineffective ablation procedure due to coagulum formation.
- the methods and systems utilize an information processor and RF output controller to carefully control the rate and amount of RF energy delivered from an RF generator to the cardiac tissue being ablated to improve the effectiveness of an ablation procedure.
- the information processor and RF output controller assures that RF energy is increased gradually during the initial ramp-up phase.
- the information processor and RF output controller regulates delivery of RF energy during the ablation episode using information gathered from a series of sensors that are delivered to the site of ablation, preferably as part of an ablation catheter.
- the series of sensors include a series of temperature sensors and/or a multiplicity of current sensors. This feedback-control assures that proper temperature is maintained at the site of ablation and provides the ability to abort an ablation procedure if effective tissue contact is not established or maintained throughout the ablation procedure.
- FIGS. 1 A AND 1 B are schematic diagrams of certain embodiments of the information processor and RF output controller and system of the current invention (FIG. 1A), and user interface (FIG. 1B) for the information processor and RF output controller.
- FIGS. 2A-B show catheter arrangements for efficient ablation
- FIGS. 3 and 4 show schematic block diagrams of an information processor and RF output controller in accordance with the invention, for regulating delivery of RF energy to cardiac tissue through an ablation catheter ⁇
- FIGS. 5A and 5B provide flow diagrams for the temperature measurements
- FIG. 5C is a block diagram illustrating real time analog computation of voltage impedance and power
- FIG. 6 shows a schematic diagram of temperature regulation circuitry used to regulate RF energy based on temperature readings.
- FIG. 7 is a block diagram showing the regulation of delivery of RF energy by an information processor and RF output controller according to one embodiment of the current invention that regulates current delivered to each ablation electrode of a series of ablation electrodes, separately using digital logic.
- FIG. 8 shows a record of a typical ablation episode using the methods and procedures of the current invention.
- FIG. 9 is a graph of logistic function with estimated probability of coagulum as the Dependent Variable, and C.I. as the Predictor Variable.
- FIGS. 10A and 10B show representative scattergrams of coagulum index values from two RF ablation patient cases.
- FIG. 10A shows results from a patient study when gradual power delivery was not applied and maximum power was set at 50 W.
- FIG. 10B shows results from a patient study using systems and methods according to the current invention where gradual power delivery was applied for each ablation episode and maximum power of the RF generator was set at 30 W.
- the methods and systems of the current invention utilize a novel information processor and RF output controller, also called a multi-channel RF ablation interface herein, to regulate delivery of radio frequency (RF) energy from an RF generator, also called an RF energy source herein, to cardiac tissue via an electrical coupling connected to a series of ablation electrodes of an ablation catheter.
- the information processor and RF output controller assures that energy is delivered in a gradually increasing manner during an initial ramp-up phase to an ablation temperature set point, and at a rate thereafter that is feedback-regulated to maintain the set-point temperature of the cardiac tissue at the site of ablation.
- the temperature set point is selectable by a user.
- the delivery of energy is also preferably feedback- regulated by other parameters such as impedance, current, and/or power delivered to the ablation catheter to assure that effective contact between the ablation electrode and the cardiac tissue is maintained.
- the information processor and RF output controller of the current invention are capable of delivering energy to each electrode of the series of ablation electrodes independently.
- the information processor and RF output controller uses analog methods for information processing and pulsewidth modulation for RF energy control.
- the information processor and RF output controller is capable of delivering RF energy to the electrodes of the series of electrodes in any order or combination using methods described herein.
- a user can select the electrode, or combination of electrodes, to which the information processor and RF output controller will deliver energy.
- the described information processor and RF output controller 100 is intended to make cardiac lesions in the human heart in conjunction with commercially available radio-frequency (RF) lesion generators (RF generators) 150 and ablation catheters 160, such as those manufactured by Cardima.
- the interface regulates RF energy delivery from the RF generator 150 to the ablation catheter 160 by temper- ature feedback using readings of thermocouple sensors 162 embedded in the catheters 160, as well as by other parameters such as impedance and differential impedance.
- Electrical communication between the information processor and RF output controller and the catheter occurs via an electrical coupling 170.
- the feedback regulation functions to maintain the electrode temperature near the preset temperature value, and to assure that effective contact between ablation electrodes 164 and cardiac tissue has been maintained for effective transmission of energy from the electrodes 164 to the cardiac tissue.
- the general design features of the multi-channel RF ablation interface (i.e. the information processor and RF output controller) of the current invention include an operating RF frequency range of about 470 to about 510 kHz; multiple, preferably eight (8), regulated electrode channels; maximum power RF energy input of about 100 watts; maximum power RF energy output for each channel of 30 Watts; and a function that provides gradually power delivery at start-up. As described below, preferably the power for each channel is typically set at about 25 to 35 watts, most preferably about 30 watts.
- the information processor and RF output controller is typically capable of receiving real-time temperature monitoring information from sensors 162 on the ablation catheter 160, and compares this information with the user defined set temperature.
- This temperature information is used to control the titration of RF energy to reach and maintain the set temperature, or to shut off RF energy delivery if a certain over-temperature cutoff is reached.
- the information processor and RF output controller also calculates real-time impedance and output power based on measurements sensed from the circuitry, then compares this calculated information to user set limits, wherein if a limit is exceeded, delivery of energy is terminated.
- the information processor and RF output controller 100 is capable of receiving and processing this information for each output channel of the circuitry.
- the information processor and RF output controller may use analog or digital methods for receiving and processing monitoring information from the sensors. In a preferred embodiment real-time analog data acquisition and computation methods are used.
- the information processor and RF output controller and/or the RF source has the ability to deliver RF energy in a gradual manner when energy delivery is initiated. That is, either in a manual, or preferably an automated manner, upon initiation of delivery of RF energy to an ablation electrode, power is initiated at a level that is below the maximum power level used to attain a temperature set point for the cardiac tissue being ablated. Power is then gradually increased over a duration of about 8 to 15 seconds, preferably 10 seconds, typically until it reaches the maximum power.
- power when using the Radionics RFG-3E generator in the manual mode, power may be commenced with a setting of 10 watts, and then gradually increased within 10 seconds by adjusting the power knob on the RF generator to reach a set temperature of 50 °C while not overshooting a maximum of 30 watts, all the while maintaining total RF delivery time at 60 seconds.
- the preferred information processor and RF output controller and RF output controller of the current invention gradually increases power automatically upon initiation of RF energy delivery. As shown in FIG 1B, the information processor and multichannel simultaneous
- RF output controller typically contains a user interface containing a series of displays 105 and 1 0, and adjustment knobs 115, 120, 125, 130, 135 to facilitate monitoring and control of the parameters described above.
- the user interface may contain a display of parameter values 105, and may preferably contain a separate thermocouple digital display 110.
- the user interface typically contains a series of adjustment knobs 115, 120, 125, 130, 135 to facilitate setting values for the parameters described above.
- the information processor and RF output controller typically includes an ablation temperature set point control 115 and over-temperature set point control 120.
- the ablation temperature set point control 115 has a range of from about 50° C to about 70° C
- the over-temperature set point control 120 has a range from about 55° C to about 75° C.
- the information processor and RF output controller preferably can determine impedance and differential impedance, typically measures power output and includes a power limit adjustment knob 125.
- the information processor and RF output controller has an impedance limit control 130 which typically can be set in the range from about 50 to about 1000 Ohms. Additionally, the information processor and RF output controller preferably has a differential impedance set point control 135 from 10 to 300 Ohms.
- the information processor and RF output controller user interface may contain a fault status indicator 40 which may project any type of signal detectable by a user if the information processor and RF output controller detects a parameter value that exceeds a preset limit.
- the fault status indicator may be triggered if the temperature of the cardiac tissue exceeds a maximum temperature set by the user.
- the fault status indicator may project a visual or auditory signals.
- the user interface includes a reset switch which resets the fault status indicator.
- the user interface on the information processor and RF output controller may have one or more of the following additional features, as described in more detail in the specific embodiment disclosed below:
- an ablate/pace mode select switch to switch between ablation and electro- cardiogram recording modes
- the information processor and RF output controller of the current invention regulates delivery of RF energy from an RF energy source through multiple channels simultaneously to cardiac tissue.
- the primary functional building block of all radio frequency (RF) energy sources developed for tissue ablation is an electronic circuit called an oscillator which generates sinusoidal waveforms at particular operating frequencies. This waveform is consequently amplified to deliver the required wattage required for tissue ablation.
- the operating frequency of this RF oscillator typically is within the range of 470 to 510 kHz.
- the quality of the oscillator and ancillary electronics design impinges on the stability of the resulting operating frequency. Hence, this operating frequency may "drift" slightly if the oscillator design is unstable.
- this frequency jitter has imperceptible influence on the resulting tissue lesion.
- certain RF oscillators or associated electronics systems generate and deliver a skewed or distorted sine wave signal that has spurious noise spikes and/or harmonics riding on top of it.
- Such "noisy" and skewed RF waveforms may result in undesirable noise artifacts may have the potential of promoting coagulum formation if they are present during the ablation process. Therefore, it is desirable for the current invention to use an RF source which produces a relatively pure and stable sine wave, preferably as pure and stable a sine wave as possible.
- the information processor and RF output controller is connected to and regulates RF energy delivered to multiple electrodes arranged in various configurations at the distal end of a catheter.
- electrodes of the catheter deliver the RF current into biological tissue.
- This RF energy in turn heats the tissue by causing ionic friction within the tissue and fluid medium encompassed by the electric field.
- this temperature rise caused by the conversion of electrical to thermal energy can be used as a guide in RF catheter ablation. Its measurement is facilitated by the placement of thermal sensors, either thermocouples or thermistors, underneath or juxtaposed with the ablative electrodes.
- the sensed temperature can also be utilized by the RF generator as a feedback signal to automatically regulate the output power to arrive at or maintain a temperature set-point predetermined by the end-user.
- ablation catheters are known in the art and can be used with the systems and methods of the current invention.
- catheters for use with the current invention have multiple electrodes and thermal sensors in close proximity to these electrodes, as discussed above.
- preferred catheters allow relatively higher electrode current densities which allow lower maximum RF generator power settings, such that effective ablation can be performed at 35 W, and more preferably 30 W, rather than 50 W.
- FIGS. 2A-2B An example of a preferred catheter (i.e., the CARDIMA RevelationTM TX 3.7 Fr catheter) for use in the current invention is illustrated in FIGS. 2A-2B.
- the catheter was developed for right atrial linear MAZE ablation, and has eight electrodes with thermocouples located in between the electrodes, to accurately sense localized tissue temperature at the ablation site.
- This preferred catheter has eight 6 mm coil electrodes with 2mm inter-electrode spacing, and 8 thermocouples located proximal to each electrode in the inter-electrode spaces.
- a 9 Fr steerable guiding catheter called the NaviportTM may be used in conjunction with this catheter to aid in placement.
- the NaviportTM may be used in conjunction with this catheter to aid in placement.
- Experience with the 3.7 Fr REVELATION Tx microcatheter has shown that it is successful in creating transmural lesions narrower and with smaller surface area than those created by standard 8 Fr ablation catheters.
- FIGS. 3 and 4 a specific embodiment is diagrammatically illustrated in FIGS. 3 and 4.
- the described embodiment provides a specific multi-channel RF ablation system with the general features illustrated in FIGS. 1A and 1B.
- the multichannel information processor and RF energy controller provides up to eight channels (switch selectable) of precise RF energy to the catheter's electrodes as well as displays the tissue temperature and impedance in real time. Measurement of the RF power delivered to the tissue, RF current, and RF voltage, as well as the differential impedance for each of the ablation elements, is also provided. All signals are available for computer monitoring or optionally displayed via front panel digital meters.
- the system incorporates a medical grade power supply approved by the international safety agencies. This power supply can be used for various line voltages and frequencies without any modification.
- the system is designed to handle up to 100 watts of input power RF energy.
- ACU analog computer unit
- the system continuously monitors and adjusts the precise RF energy delivered to each electrode.
- Over-temperature detection is provided for each channel of the system. RF energy is latched off for the entire system if an over-temperature condition is detected. Operation is resumed by power cycling or pushbutton reset. Open thermocouple detection inhibits operation of only the faulty channel. Operation is resumed automatically when the fault is cleared.
- the system is designed to comply with the requirements and standards of international electrical safety codes. It utilizes isolated circuits for all patient connections to insure patient safety even with failed components. This applies to both the thermocouple amplifiers, and the RF output circuitry.
- the over-temperature cutoff limit is provided to cut off all power delivered to the catheter in the event that any thermocouple reaches a preset over-temperature limit. Adjustment range for this function is from 55° C. to 75° C.
- a front panel control and display unit which allows a user to set a number of parameters.
- the front panel control and display can be used to set the maximum power value sent to any one electrode (Adjustment range: 1-30 watts).
- the impedance cutoff circuitry monitors each channel individually and will cause the power delivery to be interrupted from a given electrode when that electrode's impedance rises above a preset limit.
- the front panel control and display (one for the entire unit) provide a control button or knob for setting the impedance cutoff limit (Adjustment range: 50-1000 Ohms).
- the differential impedance cutoff circuitry monitors each channel individually and will interrupt power delivered to a given electrode if that electrode's impedance rises by a preset differential (above the lowest value during a given ablation run).
- the front panel control and display provides a knob for setting the differential impedance cutoff limit (Adjustment range: 10-200 Ohms).
- an active impedance network dummy loads are placed between the RF generator and the ablation circuitry.
- a mode switch (ablate/pace) is provided for switching between ablation and electrocardiogram recording modes, as well as pace threshold determination mode.
- Appropriate filtering is designed to allow recording of electrocardiogram during ablation or pacing modes.
- thermocouple 1 Used for catheters that utilize thermocouples between electrodes (e.g., thermocouple 1 is proximal to thermocouple 2).
- the system will monitor temperature on both sides of each electrode and regulate the temperature based upon the higher temperature, except for the most distal electrode, which has only one nearest thermocouple.
- thermocouple 2 Used for catheters utilizing thermocouples either under or soldered directly onto each electrode.
- the channel card functional block diagram (FIGS. 3 and 4) of the system 10 provide thermocouple inputs and patient isolation 12, pulse width modulator 14, power output RF control 16, analog computer and parameter measurement 18, impedance and differential impedance 20, fault latch control 22, and fault status 28.
- the common mode input filter is designed to handle high common mode of RF energy level on the thermocouples.
- the isolation circuits, both the power supply and the thermocouple amplifiers, are designed to isolate the patient from the main power source circuitry by 2500 volts.
- the pulse width modulator (PWM) 14 regulates the RF energy by comparing the delivered RF power (computed by the analog computer) to the preset value (PLIMIT). It also provides soft start for each channel card as well as synchronization circuitry for all eight channels.
- the soft start is a safety feature active at power on that gradually ramps up the voltage to prevent spikes on the electrodes.
- each channel has a corresponding thermocouple (T/C) sensor which provides temperature feedback information at the tissue site immediately proximal to the electrode delivering RF energy.
- T/C thermocouple
- the RF output for each electrode is modulated by a PWM chip on the channel card.
- the commercially available PWM device used is the Unitrode High Speed PWM Controller UC3823, or the equivalent chip made by MicroLinear, ML4823.
- Temperature input signals sensed from neighboring T/C's are used to control the pulse-width modulator (PWM) outputs.
- PWM pulse-width modulator
- each electrode 164 has a corresponding thermocouple sensor 162 that provides temperature feedback information at the tissue site immediately proximal to the electrode delivering the RF energy.
- Each electrode's RF output is controlled by a PWM circuit 180 located on each channel card. Temperature input signals sensed from neighboring thermocouples that are electronically subtracted from each other to form a new pulse width that will control the amount of RF energy output.
- FIG. 6 illustrates the monitoring of both sides of electrode #5 and the resulting differential PWM that will control the RF circuitry for this electrode.
- digital logic, herein NAND gate 185 is employed with inputs set by temperature thresholds taken from thermocouples adjacent to the electrodes.
- Safety features that isolate the external RF generator (coupling transformers) from the power source are implemented both on the channel card as well as common electronics board.
- the voltage, current, impedance, and output power are calculated by the analog computer unit (ACU) and the associated high precision RMS to DC converter circuitry.
- ACU analog computer unit
- the information generated by the ACU is crucial to the precise control and stability of the system. This provides real-time monitoring of the catheter's parameters and stabilizes the preset temperature for a constant stream of energy in order to create a clean and accurate lesion.
- this interface provides an impedance and delta impedance cutoff for each channel individually. This will cause the power delivery to be interrupted from a given electrode when that electrode's impedance rises above a preset limit.
- thermocouple Over temperature, open thermocouple, high impedance, and high delta impedance detection circuitry are implemented into the design of the preferred example of an information processor and RF output controller (i.e. the IntelliTemp system) described herein. System shutdown occurs for over temperature detection on any channel. Open thermocouple will inhibit operation on the affected channel only, normal operation proceeds on remaining channels.
- Sensed AC Voltage, Vj n via secondary side of the input transformer.
- Sensed AC Current, lj n , mA via precision non-inductive resistor and associated circuitry.
- the specific example of the information processor and RF output controller illustrated in FIGS. 3-7 does not rely on digital circuitry (e.g., analog-to-digital (A/D) converters, digital latches, registers, and a microprocessor) to determine sensed voltage, impedance, and power. Instead, it utilizes analog methods to provide realtime computation of RMS output, voltage, current, impedance and power.
- digital circuitry e.g., analog-to-digital (A/D) converters, digital latches, registers, and a microprocessor
- the building blocks for the real-time analog computer are illustrated in FIG. 5C and described in the following paragraphs.
- the primary building block for this analog computation circuitry is the Analog Devices AD538 Real-Time Analog Computation Unit (ACU) which provides precision analog multiplication, division, and exponentiation.
- ACU Real-Time Analog Computation Unit
- the first two mathematical operations are used, as follows: The ACU has this transfer function:
- VOUT ⁇ CU V y (V z /V x ) It should be noted that this VOUT,ACU is not the overall V 0 u ⁇ of the analog computation system; it is merely the output of the AD538 device used.
- V 2 is a DC value that is an output parameter from the second set of building blocks mentioned below, the RMS-to-DC Converter. This DC value represents the RMS voltage (V) of the RF energy being delivered at the electrode.
- V x is a DC value which has been converted from the RMS current (mA), of the RF energy being delivered at the electrode.
- This device also permits a scaling factor, V y , to be multiplied into the output transfer function. This scaling factor is set at a value of 0.1 , since the ratio of the primary to secondary coils of the input transformer is 10. Since V 2 represents voltage, and V x represents current, therefore VOUT,ACU represents the computed real-time impedance ⁇ .
- the secondary building blocks are two Analog Devices AD637 High Precision Wide-Band RMS-to-DC Converters, which serve to compute the true RMS value of an incoming AC waveform, and represent this RMS value as an equivalent DC output voltage.
- the outputs of these units are fed as input parameters into the ACU discussed above, which also supplies a true RMS value of a signal that may be more useful than an average rectified signal since it relates directly to the power of the input signal.
- the outputs of V ou t, Out. Z ou t. and P ou t, are hence all calculated in realtime.
- RF output per channel is governed by three inputs into a NAND gate (Motorola part number MC74HC10A): i. The "on time” of the pulse-width modulator for that particular channel. ii. The “on time” of the pulse-width modulator for the channel immediately proximal to the above-said channel. iii. Power Limit Set-Point that is common for all channels. This is manually set with a control knob on the instrumentation front panel.
- FIG. 7 the functional schematic of the interaction between Channel 3 input and Channel 2 output in determining Channel 3 output is shown in FIG. 7, where in the timing diagram of the Channel 3 electrode output (lower right corner) there is a slight propagation delay.
- the PWM duty cycle is governed by an oscillator that is set by an oscillating frequency determined by a resistive and a capacitive component. In the present embodiment, this frequency is set at 1.7 kHz. However, if the sensitivity of the feedback-response circuit needs to be "slowed down" to increase heat build-up in the tissue, this frequency can be decreased.
- FIG. 8 shows a typical ablation episode using the specific embodiment of the invention described above.
- Contact force is a parameter that has been measured experimentally in an in vitro setting to determine the quality of electrode-tissue contact; it has a high correlation (up to 97%) with temperature rise.
- the monitored tissue impedance and voltage is relatively constant. Therefore, the measured tissue impedance is another key parameter, because it is an indicator of electrode-tissue contact.
- the information processor and RF output controller of the current invention are designed to maximize the efficacy of an ablation procedure by minimizing coagulum formation.
- these information processor and RF output controllers, systems, and methods take advantage of the following considerations.
- the international normalization ratio (INR) was checked to be ⁇ 1.8, and a baseline activated clotting time (ACT) value was obtained.
- An initial bolus of intravenous heparin was administered, and continuously administered throughout the procedure to maintain an ACT of approximately 200 to 300 seconds.
- the ACT measurements were taken at 30 minute intervals until therapeutic levels were achieved, then every 60 minutes for the duration of the procedure. Heparin administration was adjusted according to the ACT values.
- RF ablation procedures were performed using the REVELATION Tx (CARDIMA, Fremont, CA, U.S.A.) Microcatheter. This microcatheter has eight 6 mm coil electrodes with 2 mm spacing, and eight inter-electrode thermocouples. A 9 Fr CARDIMA NAVIPORTTM steerable guiding catheter was used in conjunction with the microcatheter to aid in placement. If the target temperature was not reached, the duration to reach the maximal recorded temperature closest to the target temperature was used instead.
- the RFG-3E RF generator Radionics, Burlington, MA, U.S.A. was the RF source used for all procedures.
- Coagulum Index a value that provides insight into the likelihood of coagulum formation during an ablation procedure, and that is useful in setting parameters for an ablation procedure to minimize the potential for coagulum formation. From this model, Coagulum Index was defined:
- (W/t) is the slope or gradient of the power curve measured from the start of the ablation episode (baseline) to the time that the target temperature (i.e. set point temperature) or maximum temperature is first reached in an ablation episode.
- the derivation of the Coagulum Index which has no physical units, is included in Appendix A.
- Equation 1 Equation 1 below, where the logit risk of coagulum is the dependant variable and the coagulum index (CI.) is the independent or predictive variable.
- Figure 9 shows the graph of this logistic model.
- a threshold value for coagulum index (CI.) can be found to indicate a high probability of coagulum occurring.
- CI. coagulum index
- Table I summarizes the finding that the estimated probability of coagulum formation increases significantly when Coagulum Index increases. This analysis revealed a clear correspondence between Coagulum Index and coagulum formation.
- a distinct threshold of Coagulum Index greater than or equal to 12 was established, beyond which coagulum formation is expected. Results of this study showed that coagulum could be reduced if the slope (W/t) was gentle. This was accomplished by gradually increasing the power delivered from the RF generator, as opposed to "cranking up the watts" at the very start of an ablation episode.
- FIGS. 10A and 10B show representative scattergrams of Coagulum Index values from two RF ablation patient cases. This data supports the conclusion that the derived Coagulum Index value has pertinence and value in suggesting coagulum formation.
- coagulum was observed in many of the energy applications of FIG. 10A, especially for those having a Coagulum Index greater than 12.
- FIG. 10B lower Coagulum Indexes were obtained by gradually increasing power, in contrast to an immediate increase in power levels which was used for the energy applications shown FIG. 10A. Furthermore, the maximum power setting was reduced from 50 to 30 watts in FIG. 10B.
- one mechanism for mitigating coagulum formation is to deliver RF power in such a way that the rise time of the power, and hence temperature curve, is more gradual and consistent.
- the Radionics RFG-3E generator with a set maximum of 30 watts, one should commence with a lower power setting of 10 watts for the about first 10 seconds, and then gradually adjust the knob on the RF generator to the set maximum of 30 watts, while still maintaining total RF delivery time at 60 seconds.
- this technique was applied, it decreased coagulum formation, as is evident by the data shown in FIG. 10. Specific characteristics of RF generators must be considered to obtain the gradual power rise described above.
- the IBI-1500T has 4 user-selectable choices for controlling the power delivery ramp-up curve.
- the Osypka 300 Smart and Cordis Webster Stockert have built-in algorithms which appear to automatically regulate power delivery rise time in a gradual manner, the latter allowing the end-user to specify a temperature ramp-up time.
- the Medtronic Atakr has no user override controls for power delivery application.
- the Radionics RFG-3E allows the user to manually increase power output during the delivery of RF energy.
- the output power setting for RF energy to be delivered at the electrodes are user adjustable via the front panel knob (1-30 Watt). A lower power setting will increase the ramping time, since it takes a longer time to reach set temperature.
- An automatic algorithm which calculates the coagulum index (CI.) in real-time can be incorporated into the information processor and RF output controller functionality so that a visual or auditory signal can alert the end-user whenever the risk for coagulum formation is high, i.e. CI. greater or equal to 12.
- the information processor can calculate the CI. in real-time and use this calculated value as information that is fed back to the RF output controller functionality so that the ablation episode can be carried out with minimal probability of coagulum formation.
- Excellent electrode-tissue contact is determined by a combination of fluoroscopy, low initial impedance, and the quality of electrograms during the procedure. Results from the study reveal that excellent electrode-tissue contact, in combination with gradual RF power delivery to a maximum level of 30 to 35 watts, constitutes a sound prescription for best practice of RF ablation with the least likelihood of coagulum formation at the electrode site. Bench testing of tissue ablation has also demonstrated that good electrode contact with the tissue results in lower RF power consumption required to reach set temperature. Lower RF energy requirements in turn reduce the probability of coagulum formation.
- the insights revealed in this example may be extrapolated to procedures using other catheters for other RF ablation procedures as well, and hence are presented here.
- the catheter MAZE procedure calls for the creation of linear 'barricades' along anatomical trajectories within the right atrium, using RF ablation to compartmentalize the chamber and 'contain' pro-arrhythmic electrical propagation.
- Results of this study reveal the following considerations regarding minimizing coagulum formation during cardiac tissue ablation. In ideal situations, it is possible to achieve satisfactory tissue contact for all eight linear ablation catheter electrodes. However, the techniques discussed below yield acceptable results in right atrial MAZE linear ablation procedures even when the anatomical or flow conditions prevent optimal simultaneous contact of eight catheter electrodes. a) Excellent contact should be established in as many linear array electrodes as possible.
- b) Low tissue impedance at 'baseline' is indicative of effective contact; some RF generators permit this to be sensed and displayed prior to actual ablation by emitting a small RF current to interrogate tissue impedance at the ablation site.
- Pacing threshold if used as an indicator of contact, should be reasonable (1-2 mA); threshold values above 4-5 mA most likely indicate poor contact, and the catheter should be repositioned.
- the sheath should be rinsed periodically (e.g. every 15 minutes) with a standard heparinized saline solution bolus. This improves contact by removing coagulum build-up on the electrodes and catheter shaft.
- the catheter should be pulled out of the Naviport deflectable guiding sheath after each trajectory; the electrodes should be wiped clean if needed, before re-introducing the catheter into the Naviport.
- reduced coagulum formation can be obtained by regulating the RF power settings such that power is gradually increased and by setting the generator maximum power settings to 30W - 35W with power monitored continuously.
- the catheter should be repositioned as needed to maintain set temperature at a lower power level. It has been observed that coagulum formation is more evident when power required to maintain set temperature approaches 50 W. Conversely, coagulum formation is minimized greatly when power required is less than 35 W. This may be seen as a challenge when trying to reach set temperature.
- desired set temperature can be achieved with as low as 7 W to 15 W of power delivery. In vivo animal studies have verified deep, transmural lesions with these low power settings when there is sufficient electrode-tissue contact.
- a mathematical model for distinguishing between coagulum or non- coagulum formation on the RF-ablating electrode of the Cardima REVELATION Tx catheter was developed. This model was based on dimensional analysis of physical constants pertaining to the units for various logged parameters during RF ablation episodes, and was verified using clinical data obtained as described in the Example section.
- Y-axis Power
- X-axis Time
- this is the duration for the sensed temperature from a thermocouple to reach a set temperature, e.g., 50° C If the set temperature cannot be reached, then it is the duration for the sensed temperature to reach the maximum temperature, for that ablation episode.
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001261486A AU2001261486A1 (en) | 2000-05-12 | 2001-05-14 | Multi-channel rf energy delivery with coagulum reduction |
JP2001583643A JP2003533267A (en) | 2000-05-12 | 2001-05-14 | Multi-channel RF energy transmission system capable of reducing agglomerates |
CA002408176A CA2408176A1 (en) | 2000-05-12 | 2001-05-14 | Multi-channel rf energy delivery with coagulum reduction |
DE60136535T DE60136535D1 (en) | 2000-05-12 | 2001-05-14 | MULTI-CHANNEL HIGH FREQUENCY DELIVERY SYSTEM WITH COAGULATION REDUCTION |
EP01935386A EP1280467B8 (en) | 2000-05-12 | 2001-05-14 | Multi-channel rf energy delivery with coagulum reduction |
US10/333,113 US6936047B2 (en) | 2000-05-12 | 2001-05-14 | Multi-channel RF energy delivery with coagulum reduction |
HK03105438.6A HK1053047A1 (en) | 2000-05-12 | 2003-07-28 | Multi-channel rf energy delivery with coagulum reduction |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20384700P | 2000-05-12 | 2000-05-12 | |
US60/203,847 | 2000-05-12 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/846,260 Continuation-In-Part US7252664B2 (en) | 2000-05-12 | 2004-05-14 | System and method for multi-channel RF energy delivery with coagulum reduction |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001087172A1 WO2001087172A1 (en) | 2001-11-22 |
WO2001087172A9 true WO2001087172A9 (en) | 2003-01-03 |
Family
ID=22755574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/015346 WO2001087172A1 (en) | 2000-05-12 | 2001-05-14 | Multi-channel rf energy delivery with coagulum reduction |
Country Status (10)
Country | Link |
---|---|
US (1) | US6936047B2 (en) |
EP (1) | EP1280467B8 (en) |
JP (1) | JP2003533267A (en) |
CN (1) | CN100506183C (en) |
AT (1) | ATE413848T1 (en) |
AU (1) | AU2001261486A1 (en) |
CA (1) | CA2408176A1 (en) |
DE (1) | DE60136535D1 (en) |
HK (1) | HK1053047A1 (en) |
WO (1) | WO2001087172A1 (en) |
Families Citing this family (258)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7901400B2 (en) | 1998-10-23 | 2011-03-08 | Covidien Ag | Method and system for controlling output of RF medical generator |
US7137980B2 (en) | 1998-10-23 | 2006-11-21 | Sherwood Services Ag | Method and system for controlling output of RF medical generator |
US7364577B2 (en) | 2002-02-11 | 2008-04-29 | Sherwood Services Ag | Vessel sealing system |
US7252664B2 (en) * | 2000-05-12 | 2007-08-07 | Cardima, Inc. | System and method for multi-channel RF energy delivery with coagulum reduction |
US6989010B2 (en) * | 2001-04-26 | 2006-01-24 | Medtronic, Inc. | Ablation system and method of use |
US7163536B2 (en) * | 2004-06-10 | 2007-01-16 | Baylis Medical Company Inc. | Determining connections of multiple energy sources and energy delivery devices |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US7620451B2 (en) | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US9308043B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US9308044B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US7853333B2 (en) | 2002-04-08 | 2010-12-14 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8774922B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods |
US6978174B2 (en) | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US8175711B2 (en) | 2002-04-08 | 2012-05-08 | Ardian, Inc. | Methods for treating a condition or disease associated with cardio-renal function |
US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US7197363B2 (en) | 2002-04-16 | 2007-03-27 | Vivant Medical, Inc. | Microwave antenna having a curved configuration |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
US7044948B2 (en) | 2002-12-10 | 2006-05-16 | Sherwood Services Ag | Circuit for controlling arc energy from an electrosurgical generator |
EP1617776B1 (en) | 2003-05-01 | 2015-09-02 | Covidien AG | System for programing and controlling an electrosurgical generator system |
US7291146B2 (en) | 2003-09-12 | 2007-11-06 | Minnow Medical, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US8104956B2 (en) | 2003-10-23 | 2012-01-31 | Covidien Ag | Thermocouple measurement circuit |
US7396336B2 (en) | 2003-10-30 | 2008-07-08 | Sherwood Services Ag | Switched resonant ultrasonic power amplifier system |
US7131860B2 (en) | 2003-11-20 | 2006-11-07 | Sherwood Services Ag | Connector systems for electrosurgical generator |
US8361063B2 (en) * | 2004-06-10 | 2013-01-29 | Kimberly-Clark Inc. | System and method for controlling energy delivery |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US7628786B2 (en) | 2004-10-13 | 2009-12-08 | Covidien Ag | Universal foot switch contact port |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US8617152B2 (en) | 2004-11-15 | 2013-12-31 | Medtronic Ablation Frontiers Llc | Ablation system with feedback |
US7468062B2 (en) | 2004-11-24 | 2008-12-23 | Ablation Frontiers, Inc. | Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use |
US7429261B2 (en) | 2004-11-24 | 2008-09-30 | Ablation Frontiers, Inc. | Atrial ablation catheter and method of use |
US7601149B2 (en) * | 2005-03-07 | 2009-10-13 | Boston Scientific Scimed, Inc. | Apparatus for switching nominal and attenuated power between ablation probes |
WO2006105121A2 (en) | 2005-03-28 | 2006-10-05 | Minnow Medical, Llc | Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues |
US9474564B2 (en) * | 2005-03-31 | 2016-10-25 | Covidien Ag | Method and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generator |
US20060265031A1 (en) * | 2005-05-20 | 2006-11-23 | Medtronic, Inc. | Operation indicator for a portable therapy delivery device |
JP2009500052A (en) | 2005-06-20 | 2009-01-08 | アブレーション フロンティアズ,インコーポレーテッド | Ablation catheter |
WO2007008954A2 (en) | 2005-07-11 | 2007-01-18 | Ablation Frontiers | Low power tissue ablation system |
CN100457059C (en) * | 2005-07-12 | 2009-02-04 | 付洁宇 | Multi-path radio-frequency smelting therapic equipment |
US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
EP1922005B1 (en) * | 2005-08-25 | 2011-12-21 | Koninklijke Philips Electronics N.V. | System for electrophysiology regaining support to continue line and ring ablations |
US8550743B2 (en) * | 2005-09-30 | 2013-10-08 | Medtronic, Inc. | Sliding lock device |
US8734438B2 (en) | 2005-10-21 | 2014-05-27 | Covidien Ag | Circuit and method for reducing stored energy in an electrosurgical generator |
EP1956992B1 (en) * | 2005-12-02 | 2013-03-06 | Koninklijke Philips Electronics N.V. | Automating the ablation procedure to minimize the need for manual intervention |
US8603084B2 (en) * | 2005-12-06 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the formation of a lesion in tissue |
US9492226B2 (en) | 2005-12-06 | 2016-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Graphical user interface for real-time RF lesion depth display |
US8406866B2 (en) | 2005-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
CN103251451B (en) | 2005-12-06 | 2015-06-10 | 圣朱德医疗有限公司房颤分公司 | Assessment of electrode coupling for tissue ablation |
WO2007070361A2 (en) | 2005-12-06 | 2007-06-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US9254163B2 (en) | 2005-12-06 | 2016-02-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US10362959B2 (en) | 2005-12-06 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the proximity of an electrode to tissue in a body |
US8403925B2 (en) * | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
US7947039B2 (en) | 2005-12-12 | 2011-05-24 | Covidien Ag | Laparoscopic apparatus for performing electrosurgical procedures |
US9186200B2 (en) | 2006-01-24 | 2015-11-17 | Covidien Ag | System and method for tissue sealing |
US8147485B2 (en) | 2006-01-24 | 2012-04-03 | Covidien Ag | System and method for tissue sealing |
US7513896B2 (en) | 2006-01-24 | 2009-04-07 | Covidien Ag | Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling |
AU2007200299B2 (en) | 2006-01-24 | 2012-11-15 | Covidien Ag | System and method for tissue sealing |
CA2574935A1 (en) | 2006-01-24 | 2007-07-24 | Sherwood Services Ag | A method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm |
CA2574934C (en) | 2006-01-24 | 2015-12-29 | Sherwood Services Ag | System and method for closed loop monitoring of monopolar electrosurgical apparatus |
US8685016B2 (en) | 2006-01-24 | 2014-04-01 | Covidien Ag | System and method for tissue sealing |
US8216223B2 (en) | 2006-01-24 | 2012-07-10 | Covidien Ag | System and method for tissue sealing |
US7651493B2 (en) | 2006-03-03 | 2010-01-26 | Covidien Ag | System and method for controlling electrosurgical snares |
US7651492B2 (en) | 2006-04-24 | 2010-01-26 | Covidien Ag | Arc based adaptive control system for an electrosurgical unit |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
CN100448407C (en) * | 2006-05-17 | 2009-01-07 | 马长生 | Ablation device and probe for treating atrioventricular twitch |
US7496469B2 (en) * | 2006-05-19 | 2009-02-24 | Watlow Electric Manufacturing Company | Temperature sensor adaptors and methods |
US7496481B2 (en) * | 2006-05-19 | 2009-02-24 | Watlow Electric Manufacturing Company | Sensor adaptors and methods |
JP2009540954A (en) * | 2006-06-20 | 2009-11-26 | エーオーテックス, インコーポレイテッド | Prosthetic valve implantation site preparation technology |
EP2465574B1 (en) | 2006-06-28 | 2015-10-28 | Ardian, Inc. | Systems for thermally-induced renal neuromodulation |
US9119633B2 (en) | 2006-06-28 | 2015-09-01 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US11389232B2 (en) | 2006-06-28 | 2022-07-19 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
WO2008024714A1 (en) | 2006-08-21 | 2008-02-28 | Mayo Foundation For Medical Education And Research | Coagulum formation controlling apparatus |
US7794457B2 (en) | 2006-09-28 | 2010-09-14 | Covidien Ag | Transformer for RF voltage sensing |
EP2954868A1 (en) | 2006-10-18 | 2015-12-16 | Vessix Vascular, Inc. | Tuned rf energy and electrical tissue characterization for selective treatment of target tissues |
AU2007310991B2 (en) | 2006-10-18 | 2013-06-20 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US8226648B2 (en) | 2007-12-31 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive flexible polymer bipolar electrode |
US8460285B2 (en) | 2006-12-29 | 2013-06-11 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter electrode having multiple thermal sensors and method of use |
US7883508B2 (en) * | 2006-12-29 | 2011-02-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Contact-sensitive pressure-sensitive conductive composite electrode and method for ablation |
US7955326B2 (en) | 2006-12-29 | 2011-06-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive conductive composite electrode and method for ablation |
US9579483B2 (en) * | 2006-12-29 | 2017-02-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive conductive composite contact sensor and method for contact sensing |
US10085798B2 (en) * | 2006-12-29 | 2018-10-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation electrode with tactile sensor |
WO2008101356A1 (en) * | 2007-02-25 | 2008-08-28 | Baylis Medical Company Inc. | Methods for control of energy delivery to multiple energy delivery devices |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
US8777941B2 (en) | 2007-05-10 | 2014-07-15 | Covidien Lp | Adjustable impedance electrosurgical electrodes |
US8641704B2 (en) | 2007-05-11 | 2014-02-04 | Medtronic Ablation Frontiers Llc | Ablation therapy system and method for treating continuous atrial fibrillation |
US7834484B2 (en) | 2007-07-16 | 2010-11-16 | Tyco Healthcare Group Lp | Connection cable and method for activating a voltage-controlled generator |
US8216220B2 (en) | 2007-09-07 | 2012-07-10 | Tyco Healthcare Group Lp | System and method for transmission of combined data stream |
US8512332B2 (en) | 2007-09-21 | 2013-08-20 | Covidien Lp | Real-time arc control in electrosurgical generators |
US8906011B2 (en) | 2007-11-16 | 2014-12-09 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
US8211102B2 (en) * | 2007-12-21 | 2012-07-03 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Contact sensing flexible conductive polymer electrode |
US8500731B2 (en) * | 2007-12-21 | 2013-08-06 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Adjustable length flexible polymer electrode catheter and method for ablation |
US8290578B2 (en) | 2007-12-28 | 2012-10-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for complex impedance compensation |
US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
US8343144B2 (en) * | 2008-02-11 | 2013-01-01 | Expandoheat, Llc | Apparatus and method for vessel sealing and tissue coagulation |
US8226639B2 (en) | 2008-06-10 | 2012-07-24 | Tyco Healthcare Group Lp | System and method for output control of electrosurgical generator |
WO2010048020A1 (en) * | 2008-10-20 | 2010-04-29 | Epitome Pharmaceuticals Limited | Methods and systems for improved pharmaceutical intervention in coagulation control |
JP5307900B2 (en) | 2008-11-17 | 2013-10-02 | べシックス・バスキュラー・インコーポレイテッド | Selective energy storage without knowledge of organizational topography |
US8652129B2 (en) | 2008-12-31 | 2014-02-18 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
EP2376011B1 (en) | 2009-01-09 | 2019-07-03 | ReCor Medical, Inc. | Apparatus for treatment of mitral valve insufficiency |
US8167875B2 (en) * | 2009-01-12 | 2012-05-01 | Tyco Healthcare Group Lp | Energy delivery algorithm for medical devices |
US8262652B2 (en) | 2009-01-12 | 2012-09-11 | Tyco Healthcare Group Lp | Imaginary impedance process monitoring and intelligent shut-off |
US8211100B2 (en) * | 2009-01-12 | 2012-07-03 | Tyco Healthcare Group Lp | Energy delivery algorithm for medical devices based on maintaining a fixed position on a tissue electrical conductivity v. temperature curve |
US8333759B2 (en) * | 2009-01-12 | 2012-12-18 | Covidien Lp | Energy delivery algorithm for medical devices |
US8211097B2 (en) * | 2009-02-13 | 2012-07-03 | Cutera, Inc. | Optimizing RF power spatial distribution using frequency control |
US8298225B2 (en) * | 2009-03-19 | 2012-10-30 | Tyco Healthcare Group Lp | System and method for return electrode monitoring |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US7956620B2 (en) * | 2009-08-12 | 2011-06-07 | Tyco Healthcare Group Lp | System and method for augmented impedance sensing |
US8454589B2 (en) | 2009-11-20 | 2013-06-04 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing effective delivery of ablation therapy |
US8641708B2 (en) * | 2009-12-29 | 2014-02-04 | Biosense Webster (Israel), Ltd. | Measuring weak signals over ablation lines |
EP2555699B1 (en) | 2010-04-09 | 2019-04-03 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US8794830B2 (en) * | 2010-10-13 | 2014-08-05 | Biosense Webster, Inc. | Catheter with digitized temperature measurement in control handle |
EP3449856B1 (en) | 2010-10-25 | 2023-06-28 | Medtronic Ardian Luxembourg S.à.r.l. | Device for evaluation and feedback of neuromodulation treatment |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9788891B2 (en) | 2010-12-28 | 2017-10-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation electrode assemblies and methods for using same |
US8979840B2 (en) | 2010-12-17 | 2015-03-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Irrigant distribution system for flexible electrodes |
US9855094B2 (en) * | 2010-12-28 | 2018-01-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multi-rate fluid flow and variable power delivery for ablation electrode assemblies used in catheter ablation procedures |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
US9033973B2 (en) | 2011-08-30 | 2015-05-19 | Covidien Lp | System and method for DC tissue impedance sensing |
JP5926806B2 (en) | 2011-09-22 | 2016-05-25 | ザ・ジョージ・ワシントン・ユニバーシティThe George Washingtonuniversity | System and method for visualizing ablated tissue |
ES2727868T3 (en) | 2011-09-22 | 2019-10-21 | Univ George Washington | Systems for visualizing ablated tissue |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
WO2013059202A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CN108095821B (en) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | Orifice renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
EP2788078B1 (en) | 2011-12-09 | 2020-09-02 | Metavention, Inc. | Therapeutic neuromodulation of the hepatic system |
JP5544046B2 (en) * | 2011-12-12 | 2014-07-09 | オリンパスメディカルシステムズ株式会社 | Treatment system and method of operating a treatment system |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
EP2793690B1 (en) | 2011-12-23 | 2021-04-07 | Vessix Vascular, Inc. | Expandable balloon or an electrode pad with a heat sensing device |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
WO2013134548A2 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
AU2013229776B2 (en) | 2012-03-08 | 2016-12-15 | Medtronic Af Luxembourg S.A.R.L. | Biomarker sampling in the context of neuromodulation devices and associated systems |
US9060778B2 (en) | 2012-04-26 | 2015-06-23 | Medtronic Ablation Frontiers Llc | Intermittent short circuit detection on a multi-electrode catheter |
US20130296840A1 (en) | 2012-05-01 | 2013-11-07 | Medtronic Ablation Frontiers Llc | Systems and methods for detecting tissue contact during ablation |
US9216050B2 (en) | 2012-05-01 | 2015-12-22 | Medtronic Ablation Frontiers Llc | Detection of microbubble formation during catheter ablation |
US9095350B2 (en) | 2012-05-01 | 2015-08-04 | Medtronic Ablation Frontiers Llc | Impedance detection of venous placement of multi-electrode catheters |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US9198592B2 (en) | 2012-05-21 | 2015-12-01 | Kardium Inc. | Systems and methods for activating transducers |
US9017321B2 (en) | 2012-05-21 | 2015-04-28 | Kardium, Inc. | Systems and methods for activating transducers |
US10827977B2 (en) | 2012-05-21 | 2020-11-10 | Kardium Inc. | Systems and methods for activating transducers |
US9387032B2 (en) | 2012-06-18 | 2016-07-12 | Medtronic Ablation Frontiers Llc | Systems and methods for detecting channel faults in energy delivery systems |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US20140110296A1 (en) | 2012-10-19 | 2014-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods |
US9233225B2 (en) | 2012-11-10 | 2016-01-12 | Curvo Medical, Inc. | Coaxial bi-directional catheter |
US9549666B2 (en) | 2012-11-10 | 2017-01-24 | Curvo Medical, Inc. | Coaxial micro-endoscope |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9486272B2 (en) | 2013-03-12 | 2016-11-08 | Biosense Webster (Israel) Ltd. | Force feedback device and method for catheters |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9283028B2 (en) | 2013-03-15 | 2016-03-15 | Covidien Lp | Crest-factor control of phase-shifted inverter |
CN105228546B (en) | 2013-03-15 | 2017-11-14 | 波士顿科学国际有限公司 | Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension |
CN105473090B (en) | 2013-03-15 | 2019-05-03 | 波士顿科学国际有限公司 | Rebuild the method and device of the tissue of body passage or the tissue of neighbouring body passage |
EP3010436A1 (en) | 2013-06-21 | 2016-04-27 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
JP2016523147A (en) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal denervation balloon catheter with a riding-type electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
WO2015006480A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
WO2015006573A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10729484B2 (en) | 2013-07-16 | 2020-08-04 | Covidien Lp | Electrosurgical generator with continuously and arbitrarily variable crest factor |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
CN105555220B (en) | 2013-07-22 | 2019-05-17 | 波士顿科学国际有限公司 | Medical instrument for renal nerve ablation |
US9872719B2 (en) | 2013-07-24 | 2018-01-23 | Covidien Lp | Systems and methods for generating electrosurgical energy using a multistage power converter |
US9636165B2 (en) | 2013-07-29 | 2017-05-02 | Covidien Lp | Systems and methods for measuring tissue impedance through an electrosurgical cable |
EP3035879A1 (en) | 2013-08-22 | 2016-06-29 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
EP3041425B1 (en) | 2013-09-04 | 2022-04-13 | Boston Scientific Scimed, Inc. | Radio frequency (rf) balloon catheter having flushing and cooling capability |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US10448986B2 (en) * | 2013-09-27 | 2019-10-22 | Covidien Lp | Electrosurgical medical device with power modulation |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
US10433902B2 (en) | 2013-10-23 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Current control methods and systems |
JP2016534842A (en) | 2013-10-25 | 2016-11-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Embedded thermocouples in denervation flex circuits |
US20150141847A1 (en) | 2013-11-20 | 2015-05-21 | The George Washington University | Systems and methods for hyperspectral analysis of cardiac tissue |
US20160331447A1 (en) * | 2013-12-20 | 2016-11-17 | The Johns Hopkins University | Method and apparatus for selective treatment inside a body lumen |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
WO2015119890A1 (en) | 2014-02-04 | 2015-08-13 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
EP3875139A1 (en) | 2014-03-26 | 2021-09-08 | Venclose, Inc. | Venous disease treatment |
US9980766B1 (en) | 2014-03-28 | 2018-05-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for renal neuromodulation |
US10194979B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US10194980B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US10610292B2 (en) | 2014-04-25 | 2020-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology |
CN104083208A (en) * | 2014-07-21 | 2014-10-08 | 西安唐城电子医疗设备研究所 | Multi-channel radio frequency temperature-controlled thermal condenser |
US10405915B2 (en) | 2014-10-31 | 2019-09-10 | Medtronic Advanced Energy Llc | RF output stage switching mechanism |
CN107427213B (en) | 2014-11-03 | 2021-04-16 | 460医学股份有限公司 | System and method for evaluation of contact quality |
AU2015343258B2 (en) | 2014-11-03 | 2020-07-16 | 460Medical, Inc. | Systems and methods for lesion assessment |
US10722184B2 (en) | 2014-11-17 | 2020-07-28 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
US10368936B2 (en) | 2014-11-17 | 2019-08-06 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
AU2015350007A1 (en) | 2014-11-19 | 2017-06-29 | Epix Therapeutics, Inc. | Systems and methods for high-resolution mapping of tissue |
CA2967824A1 (en) | 2014-11-19 | 2016-05-26 | Advanced Cardiac Therapeutics, Inc. | Ablation devices, systems and methods of using a high-resolution electrode assembly |
WO2016081611A1 (en) | 2014-11-19 | 2016-05-26 | Advanced Cardiac Therapeutics, Inc. | High-resolution mapping of tissue with pacing |
WO2016090122A1 (en) | 2014-12-03 | 2016-06-09 | PAVmed Inc. | Systems and methods for percutaneous division of fibrous structures |
CN104473691B (en) * | 2014-12-30 | 2017-04-26 | 北京天助畅运医疗技术股份有限公司 | Power control system and power control method for radio frequency treatment equipment |
US9636164B2 (en) | 2015-03-25 | 2017-05-02 | Advanced Cardiac Therapeutics, Inc. | Contact sensing systems and methods |
JP6622817B2 (en) | 2015-03-31 | 2019-12-18 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Method and device for delivering pulsed RF energy during catheter ablation |
US10517670B2 (en) | 2015-07-16 | 2019-12-31 | Biosense Webster (Israel) Ltd. | Estimation of lesion size |
US10779904B2 (en) | 2015-07-19 | 2020-09-22 | 460Medical, Inc. | Systems and methods for lesion formation and assessment |
US11446078B2 (en) | 2015-07-20 | 2022-09-20 | Megadyne Medical Products, Inc. | Electrosurgical wave generator |
CN105559882A (en) * | 2015-12-15 | 2016-05-11 | 江苏邦士医疗科技有限公司 | Low-temperature plasma radio-frequency surgery system |
SG11201807618QA (en) | 2016-03-15 | 2018-10-30 | Epix Therapeutics Inc | Improved devices, systems and methods for irrigated ablation |
US10524859B2 (en) | 2016-06-07 | 2020-01-07 | Metavention, Inc. | Therapeutic tissue modulation devices and methods |
CN106175924A (en) * | 2016-06-18 | 2016-12-07 | 周玉杰 | Cardiovascular and cerebrovascular vessel soften ablating device |
JP6868097B2 (en) * | 2016-10-04 | 2021-05-12 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Methods and Devices for Estimating Tip-Tissue Connection of Ablation Catheter Chips |
US11523857B2 (en) * | 2016-12-22 | 2022-12-13 | Medtronic, Inc. | Multiplexing algorithm with power allocation |
GB2559595B (en) * | 2017-02-10 | 2021-09-01 | Creo Medical Ltd | Electrosurgical apparatus and electrosurgical instrument |
EP3585292A4 (en) * | 2017-02-23 | 2020-12-23 | Innoblative Designs, Inc. | Systems and methods for ablation status monitoring and custom ablation shaping |
EP3614946B1 (en) | 2017-04-27 | 2024-03-20 | EPiX Therapeutics, Inc. | Determining nature of contact between catheter tip and tissue |
AU2018257642B2 (en) * | 2017-04-28 | 2024-03-21 | Stryker Corporation | Control console and accessories for RF nerve ablation and methods of operating the same |
US10945781B2 (en) | 2017-09-07 | 2021-03-16 | Biosense Webster (Israel) Ltd. | Variable phase generation and detection for radio-frequency (RF) ablation |
US11116563B2 (en) | 2018-02-15 | 2021-09-14 | Biosense Webster (Israel) Ltd. | Multi-channel RF ablation |
KR102233949B1 (en) * | 2018-11-16 | 2021-03-31 | 주식회사 루트로닉 | Energy transfer module for a vagina wall treatment device, control method of a vagina wall treatment device comprising that |
CN116490239A (en) | 2020-11-09 | 2023-07-25 | 敏捷设备有限公司 | Device for steering a catheter |
US11389234B1 (en) * | 2021-02-11 | 2022-07-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for pre-ablation pulses in pulsed field ablation applications |
CN113558760A (en) * | 2021-07-27 | 2021-10-29 | 上海玄宇医疗器械有限公司 | double-MCU control system for pulsed electric field ablation equipment |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996000036A1 (en) * | 1994-06-27 | 1996-01-04 | Ep Technologies, Inc. | System for controlling tissue ablation using temperature sensors |
US5810802A (en) * | 1994-08-08 | 1998-09-22 | E.P. Technologies, Inc. | Systems and methods for controlling tissue ablation using multiple temperature sensing elements |
US5800432A (en) * | 1995-05-01 | 1998-09-01 | Ep Technologies, Inc. | Systems and methods for actively cooling ablation electrodes using diodes |
US5759847A (en) * | 1995-07-14 | 1998-06-02 | Difco Laboratories | System and apparatus for automatically transferring media |
US5971983A (en) * | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6059778A (en) * | 1998-05-05 | 2000-05-09 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method using unipolar and bipolar techniques |
US6123702A (en) * | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6245065B1 (en) * | 1998-09-10 | 2001-06-12 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6183468B1 (en) * | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
WO2000015130A2 (en) * | 1998-09-10 | 2000-03-23 | Scimed Life Systems, Inc. | Systems for controlling an ablation process performed with a heart electrocatheter |
US6264653B1 (en) * | 1999-09-24 | 2001-07-24 | C. R. Band, Inc. | System and method for gauging the amount of electrode-tissue contact using pulsed radio frequency energy |
-
2001
- 2001-05-14 EP EP01935386A patent/EP1280467B8/en not_active Expired - Lifetime
- 2001-05-14 AT AT01935386T patent/ATE413848T1/en not_active IP Right Cessation
- 2001-05-14 AU AU2001261486A patent/AU2001261486A1/en not_active Abandoned
- 2001-05-14 CA CA002408176A patent/CA2408176A1/en not_active Abandoned
- 2001-05-14 CN CNB018124070A patent/CN100506183C/en not_active Expired - Fee Related
- 2001-05-14 DE DE60136535T patent/DE60136535D1/en not_active Expired - Lifetime
- 2001-05-14 WO PCT/US2001/015346 patent/WO2001087172A1/en active Application Filing
- 2001-05-14 JP JP2001583643A patent/JP2003533267A/en active Pending
- 2001-05-14 US US10/333,113 patent/US6936047B2/en not_active Expired - Lifetime
-
2003
- 2003-07-28 HK HK03105438.6A patent/HK1053047A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1440258A (en) | 2003-09-03 |
AU2001261486A1 (en) | 2001-11-26 |
JP2003533267A (en) | 2003-11-11 |
HK1053047A1 (en) | 2003-10-10 |
CN100506183C (en) | 2009-07-01 |
EP1280467A1 (en) | 2003-02-05 |
WO2001087172A1 (en) | 2001-11-22 |
CA2408176A1 (en) | 2001-11-22 |
EP1280467B8 (en) | 2009-11-18 |
US6936047B2 (en) | 2005-08-30 |
US20040006337A1 (en) | 2004-01-08 |
ATE413848T1 (en) | 2008-11-15 |
DE60136535D1 (en) | 2008-12-24 |
EP1280467B1 (en) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6936047B2 (en) | Multi-channel RF energy delivery with coagulum reduction | |
US7252664B2 (en) | System and method for multi-channel RF energy delivery with coagulum reduction | |
EP1810630B1 (en) | System for terminating treatment in impedance feedback algorithm | |
JP6843579B2 (en) | Systems and methods for controlling catheter power based on renal ablation response | |
US8784410B2 (en) | Return electrode temperature prediction | |
EP1592355B1 (en) | Ablation system | |
US5720744A (en) | Control system for neurosurgery | |
EP2296572B1 (en) | System and method for output control of electrosurgical generator | |
US5334193A (en) | Fluid cooled ablation catheter | |
US7824399B2 (en) | Ablation system and method of use | |
EP2112908B1 (en) | Control of energy delivery to multiple energy delivery devices | |
EP1862137B1 (en) | System for controlling tissue heating rate prior to cellular vaporization | |
EP2213255B1 (en) | Energy delivery algorithm for medical devices | |
EP2499982B1 (en) | Energy-based ablation completion algorithm | |
CN113453637B (en) | Ablation system and nerve detection equipment thereof | |
Chan | New Concepts in Radiofrequency Energy Delivery and Coagulum Reduction During Catheter Ablation: Energy Delivery Management and a Quantitative Measure for Estimating the Probability of Coagulum Formation During Radiofrequency Ablation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2408176 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001935386 Country of ref document: EP |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/13-13/13, DRAWINGS, REPLACED BY NEW PAGES 1/13-13/13 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018124070 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10333113 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001935386 Country of ref document: EP |